Goldman Sachs
PRTK

Goldman Sachs’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-36,773
Closed -$93.4K 5229
2023
Q1
$93.4K Buy
36,773
+11,284
+44% +$28.7K ﹤0.01% 4682
2022
Q4
$47.7K Sell
25,489
-52,328
-67% -$97.9K ﹤0.01% 4795
2022
Q3
$200K Sell
77,817
-14,131
-15% -$36.3K ﹤0.01% 4721
2022
Q2
$177K Sell
91,948
-167,994
-65% -$323K ﹤0.01% 4944
2022
Q1
$772K Buy
259,942
+5,629
+2% +$16.7K ﹤0.01% 4299
2021
Q4
$1.14M Sell
254,313
-18,126
-7% -$81.4K ﹤0.01% 3925
2021
Q3
$1.32M Buy
272,439
+17,814
+7% +$86.6K ﹤0.01% 3792
2021
Q2
$1.74M Buy
254,625
+10,266
+4% +$70K ﹤0.01% 3617
2021
Q1
$1.73M Sell
244,359
-3,220
-1% -$22.7K ﹤0.01% 3498
2020
Q4
$1.55M Buy
247,579
+91,158
+58% +$570K ﹤0.01% 3217
2020
Q3
$846K Sell
156,421
-69,733
-31% -$377K ﹤0.01% 3400
2020
Q2
$1.18M Buy
226,154
+9,844
+5% +$51.4K ﹤0.01% 3137
2020
Q1
$681K Sell
216,310
-125,012
-37% -$394K ﹤0.01% 3326
2019
Q4
$1.38M Buy
341,322
+208,755
+157% +$842K ﹤0.01% 3151
2019
Q3
$572K Buy
132,567
+92,844
+234% +$401K ﹤0.01% 3535
2019
Q2
$158K Sell
39,723
-27,256
-41% -$108K ﹤0.01% 3928
2019
Q1
$359K Sell
66,979
-15,192
-18% -$81.4K ﹤0.01% 3682
2018
Q4
$421K Buy
82,171
+42,930
+109% +$220K ﹤0.01% 3470
2018
Q3
$381K Sell
39,241
-124,937
-76% -$1.21M ﹤0.01% 3559
2018
Q2
$1.68M Buy
164,178
+113,505
+224% +$1.16M ﹤0.01% 2961
2018
Q1
$659K Buy
50,673
+3,345
+7% +$43.5K ﹤0.01% 3364
2017
Q4
$847K Sell
47,328
-78,043
-62% -$1.4M ﹤0.01% 3218
2017
Q3
$3.15M Sell
125,371
-6,352
-5% -$159K ﹤0.01% 2629
2017
Q2
$3.18M Buy
131,723
+88,222
+203% +$2.13M ﹤0.01% 2528
2017
Q1
$837K Sell
43,501
-11,094
-20% -$213K ﹤0.01% 3211
2016
Q4
$841K Sell
54,595
-632
-1% -$9.74K ﹤0.01% 3174
2016
Q3
$719K Sell
55,227
-16,107
-23% -$210K ﹤0.01% 3233
2016
Q2
$992K Buy
+71,334
New +$992K ﹤0.01% 2936
2015
Q2
Sell
-11,679
Closed -$365K 4775
2015
Q1
$365K Buy
+11,679
New +$365K ﹤0.01% 3516
2013
Q4
Sell
-26,033
Closed -$83K 4347
2013
Q3
$83K Sell
26,033
-348
-1% -$1.11K ﹤0.01% 4043
2013
Q2
$80K Buy
+26,381
New +$80K ﹤0.01% 3833